Evaluation of latex-Rickettsia rickettsii test for Rocky Mountain spotted fever in 11 laboratories. 1983

K E Hechemy, and E E Michaelson, and R L Anacker, and M Zdeb, and S J Sasowski, and K T Kleeman, and J M Joseph, and J Patel, and J Kudlac, and L B Elliott

A latex-Rickettsia rickettsii test for detection of antibodies to Rocky Mountain spotted fever (RMSF) was evaluated during the 1980 RMSF season in 11 laboratories in nine states where the disease is endemic. In a double-blind study, all sera submitted to each laboratory for RMSF testing were also examined by the latex-R. rickettsii test. A portion of each specimen was then sent to the New York State laboratory for testing by latex-R. rickettsii and by the reference microimmunofluorescence test. Results were exchanged at the end of the examination period. At the usual ratio of reactive to nonreactive sera encountered in a diagnostic laboratory on a day-to-day basis, the efficiency of the latex-R. rickettsii test relative to microimmunofluorescence was 96.79% for New York and 93.30% for the collaborating laboratories. Both the latex and microimmunofluorescence tests detected antibodies to RMSF within 7 to 9 days of onset. With the latex-R. rickettsii test--but not necessarily with microimmunofluorescence--a high titer (greater than or equal to 128) on a single serum was diagnostic of active RMSF. Changes in serum titer for patients with multiple sera were similar for both tests. The test detects rickettsial antibodies in patients with active infection, but in most cases it does not detect antibody in patients with past infection. Test reactivity could not be uniquely linked to a particular immunoglobulin class.

UI MeSH Term Description Entries
D007841 Latex Fixation Tests Passive agglutination tests in which antigen is adsorbed onto latex particles which then clump in the presence of antibody specific for the adsorbed antigen. (From Stedman, 26th ed) Latex Agglutination Tests,Agglutination Test, Latex,Agglutination Tests, Latex,Fixation Test, Latex,Fixation Tests, Latex,Latex Agglutination Test,Latex Fixation Test,Test, Latex Agglutination,Test, Latex Fixation,Tests, Latex Agglutination,Tests, Latex Fixation
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D012284 Rickettsia rickettsii A species of gram-negative, aerobic bacteria that is the etiologic agent of ROCKY MOUNTAIN SPOTTED FEVER. Its cells are slightly smaller and more uniform in size than those of RICKETTSIA PROWAZEKII.
D012373 Rocky Mountain Spotted Fever An acute febrile illness caused by RICKETTSIA RICKETTSII. It is transmitted to humans by bites of infected ticks and occurs only in North and South America. Characteristics include a sudden onset with headache and chills and fever lasting about two to three weeks. A cutaneous rash commonly appears on the extremities and trunk about the fourth day of illness. Sao Paulo Typhus,Typhus, Sao Paulo,Brazilian Spotted Fever,Rickettsia rickettsii Infection,Fever, Brazilian Spotted,Infection, Rickettsia rickettsii,Rickettsia rickettsii Infections,Spotted Fever, Brazilian

Related Publications

K E Hechemy, and E E Michaelson, and R L Anacker, and M Zdeb, and S J Sasowski, and K T Kleeman, and J M Joseph, and J Patel, and J Kudlac, and L B Elliott
April 2021, Emerging infectious diseases,
K E Hechemy, and E E Michaelson, and R L Anacker, and M Zdeb, and S J Sasowski, and K T Kleeman, and J M Joseph, and J Patel, and J Kudlac, and L B Elliott
September 2014, The American journal of tropical medicine and hygiene,
K E Hechemy, and E E Michaelson, and R L Anacker, and M Zdeb, and S J Sasowski, and K T Kleeman, and J M Joseph, and J Patel, and J Kudlac, and L B Elliott
December 1954, Journal of immunology (Baltimore, Md. : 1950),
K E Hechemy, and E E Michaelson, and R L Anacker, and M Zdeb, and S J Sasowski, and K T Kleeman, and J M Joseph, and J Patel, and J Kudlac, and L B Elliott
January 1987, Science (New York, N.Y.),
K E Hechemy, and E E Michaelson, and R L Anacker, and M Zdeb, and S J Sasowski, and K T Kleeman, and J M Joseph, and J Patel, and J Kudlac, and L B Elliott
May 1985, The Journal of infectious diseases,
K E Hechemy, and E E Michaelson, and R L Anacker, and M Zdeb, and S J Sasowski, and K T Kleeman, and J M Joseph, and J Patel, and J Kudlac, and L B Elliott
May 1978, Infection and immunity,
K E Hechemy, and E E Michaelson, and R L Anacker, and M Zdeb, and S J Sasowski, and K T Kleeman, and J M Joseph, and J Patel, and J Kudlac, and L B Elliott
September 1952, Zeitschrift fur Hygiene und Infektionskrankheiten; medizinische Mikrobiologie, Immunologie und Virologie,
K E Hechemy, and E E Michaelson, and R L Anacker, and M Zdeb, and S J Sasowski, and K T Kleeman, and J M Joseph, and J Patel, and J Kudlac, and L B Elliott
June 1977, The Journal of infectious diseases,
K E Hechemy, and E E Michaelson, and R L Anacker, and M Zdeb, and S J Sasowski, and K T Kleeman, and J M Joseph, and J Patel, and J Kudlac, and L B Elliott
July 1979, The Journal of pediatrics,
K E Hechemy, and E E Michaelson, and R L Anacker, and M Zdeb, and S J Sasowski, and K T Kleeman, and J M Joseph, and J Patel, and J Kudlac, and L B Elliott
January 2016, Journal of histotechnology,
Copied contents to your clipboard!